Improved Blood Pressure Control to Reduce Cardiovascular Disease Morbidity and Mortality: The Standardized Hypertension Treatment and Prevention Project

Journal of Clinical Hypertension

Volumn 18, Issue 12, 2016, Pages 1284-1294

  Patel, Pragna ^a   Ordunez, Pedro ^b   DiPette, Donald ^c,d   Escobar, Maria Cristina ^e   Hassell, Trevor ^f   Wyss, Fernando ^g   Hennis, Anselm ^b   Asma, Samira ^a   Angell, Sonia ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e Ministerio de Salud de Chile   (Chile)

^f Healthy Caribbean Coalition   (Barbados)

^g Interamerican Society of Cardiology   (Guatemala)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS BENAZEPRIL; AMLODIPINE PLUS HYDROCHLOROTHIAZIDE PLUS VALSARTAN; AMLODIPINE PLUS VALSARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ESSENTIAL DRUG; GENERIC DRUG; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; LISINOPRIL; LOSARTAN; METOPROLOL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VALSARTAN;

ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHRONIC DISEASE; COMMUNITY PROGRAM; DRUG CHOICE; DRUG COST; DRUG DOSE INCREASE; EMPOWERMENT; EVIDENCE BASED PRACTICE; FUNDING; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH PROMOTION; HELP SEEKING BEHAVIOR; HOME MONITORING; HUMAN; HYPERTENSION; LONG TERM CARE; LOW INCOME COUNTRY; MEDICATION COMPLIANCE; MIDDLE INCOME COUNTRY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; SELF CARE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASES; COMPLICATION; EVIDENCE BASED MEDICINE; FEMALE; MALE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; RISK FACTOR; STANDARDS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERTENSION; MALE; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 84978064546     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12861     Document Type: Article

References (55)

1. WHO. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization, 2015.
2. WHO. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization, 2009.
3. Causes of Death 2008: data sources and methods. Geneva; World Health Organization http://www.who.int/healthinfo/global-burden-disease/cod-2008-sources-methods.pdf. Accessed September 10, 2013.
4. GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks and clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386: 2287–2323.
5. Jaffe MG, Lee GA, Young JD, et al. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310:699–705.
6. McAlister FA, Wilkins K, Joffres M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011;183:1007–1013.
7. Pereira M, Lunet N, Azavedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27:963–975.
8. Chow CK, Teo KK, Rangarajan S, et al; and the PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013; 310: 959–968.
9. Gaziano TA, Bitton A, Weinstein AS, for the International Society of Hypertension. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27:1472–1477.
10. Jackson R, Lawes CMM, Bennett DA, et al. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005;365:434–441.
11. Nugent R. Benefits and Costs of the Noncommunicable Disease Targets for the Post-2015 Development Agenda. Copenhagen Consensus Center. Perspective Paper. 2015.
12. MacMahon S, Alderman MH, Lindholm LH, et al. Blood-pressure-related disease is a global health priority. Lancet. 2008;371:1480–1482.
13. Ikeda N, Sapienza D, Guerrero R, et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2014;92:10–19C.
14. Allain TJ, van Oosterhout JJ, Douglas GP, et al. Applying lessons learnt for ‘DOTS’ Tuberculosis Model to monitoring and evaluating persons with diabetes mellitus in Blantyre, Malawi. Tropical Med Int Health. 2011;16:1077–1084.
15. Harries AD, Zachariah R, Jahn A, et al. Scaling up antiretroviral therapy in Malawi – implications for managing other chronic diseases in resource-limited countries. J Acquired Immune Deficiency Syndrome. 2009;52:S14–S16.
16. Mullins J. Cohort reporting improves hypertension care for refugees. Lancet. 2012;380:552.
17. Seita A, Harries AD. All we need to know if public health we can learn from tuberculosis care: lessons for non-communicable disease. Int J Tuberculosis Lung Dis. 2013;17:429–430.
18. Angell SY, DeCock KM, Frieden TR. A public health approach to global management of hypertension. Lancet. 2015;385:825–827.
19. Ordunez P, Martines R, Niebylski ML, Campbell NR. Hypertension prevention and control in Latin America and the Caribbean. J Clin Hypertens (Greenwich). 2015;17:499–502.
20. Patel P, DiPette DJ. Hypertension-related congestive heart failure in West Africa: a framework for global blood pressure control. J Clin Hypertens (Greenwich). 2015;17:260–262.
21. WHO. Innovative care for chronic conditions: building blocks for action: global report. Geneva, Switzerland: World Health Organization; 2002. Available at: http://www.who.int/chp/knowledge/publications/icccglobalreport.pdf. Accessed April 1, 2015.
22. Chobanian AV, Bakris GL, Black HR, Cushman WC. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA. 2003;289:2560.
23. Thompson AE, Anisimowicz Y, Miedema B, et al. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Family Practice. 2016;17:38–44.
24. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community. A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;32:3–15.
25. Kaplan WA, Ritz LS, Vitello M, Wirtz VJ. Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000–2010. Health Policy. 2012;106:211–224.
26. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Effective Clinical Practice. 1998;1:2–4.
27. Ham C. The ten characteristics of the high-performing chronic care system. Health Economics, Policy Law. 2010;5:71–90. doi:10.1017/S1744133109990120.
28. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288:1775–1779.
29. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288:2469–2475.
30. Barcelo A, Luciani S, Agurto I, et al. Improving chronic illness care through integrated health service delivery networks. Editors. Washington, DC: Pan American Health Organization; 2012. Available at: http://new.paho.org/hq/index.php?option=com-docman&task=-doc-view&gid=17652&Itemid==.
31. WHO. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva: World Health Organization, 2010.
32. Wagner E, Austin B, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff. 2001;20:64–78.
33. Parchman ML, Zeber JE, Romero RR, Pugh JA. Risk of coronary artery disease in type 2 diabetes and the delivery of care consistent with the chronic care model in primary care settings: a STARNet study. Med Care. 2007;45:1129–1134.
34. Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the Chronic Care Model in the new millennium. Health Aff. 2009;28:75–85.
35. Go AS, Bauman MA, Coleman King SM, et al; American Heart Association; American College of Cardiology; Centers for Disease Control and Prevention. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2014; 63:878–885.
36. CDC. Global Standardized Hypertension Treatment Project: identification of a core set of medications & care delivery models for the medical treatment of hypertension. Atlanta: Centers for Disease Control and Prevention, 2013. http://www.cdc.gov/globalhealth/ncd/pdf/GSHTPp-march2013.pdf. Accessed May 1, 2015.
37. U.S. Department of Health and Human Services, National Institutes of Health. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Washington, DC: Government Printing Office; 2003. NIH Publication No. 03-5233.29.
38. Ordunez P, Luciani S, Barojas A, et al. A public health approach to hypertension. Lancet. 2015;385:1833.
39. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory setting. Cochrane Database Syst Rev. 2004;(2):CD004804.
40. Frank J. Managing hypertension using combination therapy. Am Fam Physician. 2008;77:1279–1286.
41. Pan American Health Organization (PAHO). Improving Chronic Illness Care through Integrated Health Service Delivery Networks. Washington DC: PAHO; 2012. Available at: http://new.paho.org/hq/index.php?option=com-docman&task=-doc-view&gid=17652&Itemid==. Accessed April 1, 2015.
42. Garg A, Adhikari N, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293:1223–1238.
43. Bright TJ, Wong A, Dhurjati R, et al. Effect of clinical decision-support systems: a systematic review. Ann Inter Med. 2012;157:29–43.
44. Rittenhouse D, Shortell S. The patient-centered medical home. Will it stand the test of health reform? [Commentary]. JAMA. 2009;301:2038–2040.
45. Institute of Medicine. Promoting cardiovascular health in the developing world: a critical challenge to achieve global health. Washington, DC: The National Academies Press; 2010.
46. Arnett DK, Goodman RA, Halperin JL, et al. AHA/ACC/HHS/ Strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions. Circulation. 2014;130:1662–1667.
47. Centers for Disease Control and Prevention (CDC). Self-Measured Blood Pressure Monitoring: Actions Steps for Public Health Practitioners. Atlanta, Georgia: CDC; 2013.
48. Lorig K, Sobel D, Ritter P, et al. Effect of a self-management program on patients with chronic diseases. Effective Clin Practice. 2001;4:256–262.
49. CDC. Vital signs: awareness and treatment of uncontrolled hypertension among adults—United States, 2003–2010. MMWR. 2012;61:703–709.
50. Sookaneknun P, Saramunee K, Rattarom R, et al. Economic analysis of the diabetes and hypertension screening collaboration between community pharmacies and a Thai government primary care unit. Primary Care Diabetes. 2010;4:155–164.
51. Jafar HT, Hatcher J, Poulter N, et al. Community-based interventions to promote blood pressure control in a developing country. Ann Intern Med. 2009;151:593–601.
52. Barr V, Robinson S, Marin-Link B, et al. The expanded Chronic Care Model: an integration of concerns and strategies from population health promotion and the Chronic Care Model. Hospital Quarterly. 2003;71:73–78.
53. WHO. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: World Health Organization, 2013.
54. Adler AJ, Prabhakaran D, Bovet P, et al. Reducing cardiovascular mortality through prevention and management of raised blood pressure: a World Heart Federation roadmap. Glob Heart. 2015;10:111–122.
55. Perel P, Avezum A, Huffman M, et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the World Heart Federation roadmap for secondary prevention of cardiovascular disease. Glob Heart. 2015;10:99–110.